News
USP Offers Herbal Medicines Compendium
21 May 2013
USP's standards for pharmaceuticals are contained in the United States Pharmacopeia and the National Formulary (USP?NF), which are recognized in US law and used throughout the world. ?USP believes that public standards are critically important to help ...
Click on the link to read the full article at Pharmaceutical Technology Magazine (This link will open in a new window)Are Pharmaceutical Patents A Barrier to Access to Medicines? The Importance ...
21 May 2013
Critics argue that pharmaceutical patents are a barrier to wide-reaching access to medicines, especially for vulnerable populations in the developing world. They cast their argument in the phrase, ?Patents Kill? and advocate against intellectual ...
Click on the link to read the full article at IPWatchdog.com (This link will open in a new window)PERFORMING BIOTECHNOLOGY and DRUGS COMPANIES: Aegerion ...
21 May 2013
Huntington Beach, CA -- (SBWIRE) -- 05/21/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, hidden, and undiscovered stocks traded on the NASDAQ, ...
Click on the link to read the full article at SBWire (press release) (This link will open in a new window)Plandai Biotechnology, Inc. Product Proven to Decrease Healing Time of Sports ...
21 May 2013
NEW YORK, NY--(Marketwired - May 21, 2013) - In a series of articles to introduce Planda
Click on the link to read the full article at Marketwire (press release) (This link will open in a new window)Groundbreaking germ-fighting vaccine research to be presented at National ...
21 May 2013
A novel vaccine study from South Dakota State University (SDSU) will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC). The meeting takes ...
Click on the link to read the full article at News-Medical.net (This link will open in a new window)Research explores pharmaceutical advances for IBS, hepatitis C
21 May 2013
Research presented at Digestive Disease Week- (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C. An international study holds promising results for patients suffering from IBS-D. In the ...
Click on the link to read the full article at News-Medical.net (This link will open in a new window)Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign ...
21 May 2013
Today the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launched the 'Do You Mind?' campaign to focus attention and to prompt action on MNDs. The campaign launch takes place at the start of the 66th World Health ...
Click on the link to read the full article at Canada NewsWire (press release) (This link will open in a new window)Syria pharmaceutical production slashed by war, says report
20 May 2013
Syria's pharmaceutical industry once catered to 90 percent of the population's needs, but a shortage of foreign currency has brought production to a near halt, a pro-regime daily reported on Monday. The central bank previously provided local industries ...
Click on the link to read the full article at Al-Arabiya (This link will open in a new window)Biotechnology ETF Investing 101 - ETF News And Commentary
20 May 2013
With ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S. biotech sector represents an attractive investment opportunity thanks to increased ...
Click on the link to read the full article at NASDAQ (This link will open in a new window)ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index
20 May 2013
The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). These companies must meet ...
Click on the link to read the full article at MarketWatch (press release) (This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
